Cargando…
AMPK activation protects astrocytes from hypoxia-induced cell death
Adenosine monophosphate (AMP)-activated protein kinase (AMPK) is a major cellular energy sensor that is activated by an increase in the AMP/adenosine triphosphate (ATP) ratio. This causes the initiation of adaptive cellular programs, leading to the inhibition of anabolic pathways and increasing ATP...
Autores principales: | Barialai, Leli, Strecker, Maja I., Luger, Anna-Luisa, Jäger, Manuel, Bruns, Ines, Sittig, Alina C.M., Mildenberger, Iris C., Heller, Sonja M., Delaidelli, Alberto, Lorenz, Nadja I., Voss, Martin, Ronellenfitsch, Michael W., Steinbach, Joachim P., Burger, Michael C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138264/ https://www.ncbi.nlm.nih.gov/pubmed/32323755 http://dx.doi.org/10.3892/ijmm.2020.4528 |
Ejemplares similares
-
Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet
por: Voss, Martin, et al.
Publicado: (2018) -
Activating transcription factor 4 mediates adaptation of human glioblastoma cells to hypoxia and temozolomide
por: Lorenz, Nadja I., et al.
Publicado: (2021) -
Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment
por: Heinzen, Dennis, et al.
Publicado: (2019) -
Doxycycline Impairs Mitochondrial Function and Protects Human Glioma Cells from Hypoxia-Induced Cell Death: Implications of Using Tet-Inducible Systems
por: Luger, Anna-Luisa, et al.
Publicado: (2018) -
The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma
por: Foltyn, Martha, et al.
Publicado: (2019)